Cleerly

No lunch plans? No problem! ???? Stop by booth 16033 for a meet & greet + lunch buffet with our leadership team at #ACC25! Meet the physicians, clinical innovators, and pioneers helping shape the future of cardiac care. Connect with Founder & CEO James Min, MD, CMO James P Earls MD, FSCCT, CSO Udo Hoffmann MD MPH, and CCO Jim Hartman over great food and even better conversation. See you there! ?? #YesCCT #DigitalHealth #HealthcareInnovation

?? #ACC25 is here, and so is Cleerly! ?? We're live at Booth 16033, ready to connect, showcase our latest clinical insights and give you a hands-on look at how our AI-powered technology is shaping the future of cardiac care. Live demos, expert discussions, and game-changing research—don’t miss out! ?? Check out our full schedule & book a meeting here: https://lnkd.in/gtdjSHwr #DigitalHealth #HealthcareInnovation #YesCCT #CTFirst

We track risk factors for coronary artery disease (CAD), but how are we tracking the disease itself? ???? Meet Cleerly COMPARE a revolutionary feature that empowers physicians to track CAD over time to help personalize treatment and optimize patient care. With COMPARE, healthcare professionals can: ?? Assess plaque stabilization or progression with AI-powered insights ?? Help guide treatment using analyses of two or more CCTAs ?? Evaluate CAD progression over time for truly individualized care This isn't just about detection, it's about taking action. Learn more here: https://lnkd.in/g9QTMQSZ #HealthcareInnovation #CoronaryArteryDisease #DigitalHealth #YesCCT #CardiacCare

?? #ACC25 is almost here! ?? Team Cleerly is excited to join the American College of Cardiology to share the latest in cardiac research and innovation. https://lnkd.in/gngCCCdC This year, we’re unveiling late-breaking clinical findings on the role of AI-QCT in identifying unique cardiovascular risks for women, a potential breakthrough in personalized care and enhancing health equity. Join us for: ?? 6 research abstracts ?? Health Equity Panel with CEO & Founder James Min, MD ?? Lounge & Learn Session with VP of Medical Affairs Michelle Gearhart ?? Meet & Greet with Cleerly Leadership Stop by booth #16033 for a live demo of our AI-enabled CCTA solution, delivering comprehensive, accurate and trackable insights to personalize heart attack prevention. ?? Read the full press release: https://lnkd.in/gX_YRmdW #ACC #ACC25 #YesCCT #CTFirst

What an unforgettable day in Chicago! Have you ever seen a CT scanner on wheels?! ???? In partnership with Corazon Imaging, Philips and local physicians, we provided 14 Cleerly analyses and on-site CCTA scans to raise awareness, improve education, and embrace equitable access to advanced heart care. A HUGE thank you to the American College of Cardiology for the opportunity to connect with the Chicago community and provide education on how Cleerly empowers healthcare professionals with our noninvasive, AI-powered analysis. At Cleerly, we believe in a future where cardiac care is proactive, precise, and truly personalized. Everyone deserves the opportunity to take control of their heart health, and we are honored to play a role in making that a reality. ??? #ACC25 #YesCCT #CTFirst #HealthcareInnovation

Today, we give back to empower a heart-healthier Chicago. ???? In partnership with Corazon Imaging and Philips, Cleerly is proud to support local physicians and bring our AI-powered technology directly to the community at the American College of Cardiology's Chicago Community Health Fair. With Corazon’s mobile CT scanner and Philips’s imaging technology, we’re making proactive, noninvasive cardiac care more accessible and helping educate individuals on the importance of gaining clarity about their true heart health. ?? Read the full press release here: https://lnkd.in/gJbKdwEQ #ACC #ACC25 #HealthEquity #HealthcareInnovation

?? Low-density, non-calcified plaques pose a serious threat! These unstable plaques can rupture, leading to blood clots that may block arteries and cause heart attacks. Cleerly's AI-enabled CCTA solution offers comprehensive, accurate, and trackable insights to personalize heart attack prevention strategies. Discover how we can help save lives with early detection. Learn more here: https://lnkd.in/g2cXZf34 #YesCCT #CCTA #ArterialPlaque #CardiacImaging

Women remain underdiagnosed and undertreated for coronary artery disease, but advancements in AI-powered plaque analysis could help close this gap. ???? In our latest webinar, Dr. Fatima Rodriguez dives into the benefits of coronary CTA and AI-powered plaque analysis in improving cardiovascular risk assessment for women. Learn how recognizing female-specific risk factors can enhance prevention and treatment strategies. ?? Watch now: https://lnkd.in/g_6PgGXG #YesCCT #CTFirst #WomensHistoryMonth #DigitalHealth #WomensHealth

?? Team Cleerly is heading to ACC.25 and we can't wait to connect! Join us as we share how our AI-powered plaque analysis is setting a new standard in cardiac care. https://lnkd.in/gtdjSHwr Our busy schedule includes key sessions where Cleerly leadership will discuss AI, cardiovascular disease prevention, and the latest clinical research. Plus, live demos daily at Booth 16033. ?? We're honored to participate in this incredible event and eager to showcase how our advanced AI technology empowers healthcare professionals to make confident, data-driven decisions for their patients. ?? Book a meeting or find more details here: https://lnkd.in/gtdjSHwr #ACC25 #YesCCT #CTFirst #DigitalHealth #Cardiology

?? Yes, Yes, Yes, and you guessed it, Yes! ?? If coronary computed tomography angiography (CCTA) isn’t part of your standard of care, it’s time to rethink your approach. CCTA provides comprehensive cardiac imaging, detecting key signs of heart disease like atherosclerosis and stenosis. It’s backed by the American College of Cardiology & American Heart Association with a Class 1, Level A recommendation—the strongest possible endorsement, supported by multiple randomized clinical trials. Combine CCTA with Cleerly, and you’ve got next-level precision! Our AI analyzes patients' CCTA images to characterize and quantify plaque to predict future cardiovascular risk. ?? See how Cleerly can transform your practice. Schedule a 1:1 demo today: https://lnkd.in/g7D-4dDa #YesCCT #CCTA #CTFirst #CardiacImaging